Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth E Powell

Showing results (41-50 of 113) with videos related to

Pageof 12
Sort By:
The Medical Journal of Australia|September 11, 2025
Cause-specific mortality among Queensland people with cirrhosis, by cirrhosis aetiology and decompensation status, 2007-22: a retrospective cohort studyVikas Bhasker, Jessica R Fong, Paul J Clark, et al.
Hepatology (Baltimore, Md.)|May 4, 2004
Steatosis and liver cell apoptosis in chronic hepatitis C: a mechanism for increased liver injuryMeagan J Walsh, Daina M Vanags, Andrew D Clouston, et al.
International Journal for Equity in Health|February 19, 2020
Hospitalisation for cirrhosis in Australia: disparities in presentation and outcomes for Indigenous AustraliansPatricia C Valery, Paul J Clark, Gregory Pratt, et al.
European Journal of Immunology|May 27, 2004
Virus-specific CD8+ T lymphocytes within the normal human liverScott M Ward, Julie R Jonsson, Sophie Sierro, et al.
Australian Health Review : a Publication of the Australian Hospital Association|March 2, 2013
Use of standardised assessment forms in referrals to hepatology outpatient services: implications for accurate triaging of patients with chronic hepatitis CLeigh Horsfall, Graeme Macdonald, Ian Scott, et al.
Journal of Hepatology|September 6, 2005
Adiponectin and its receptors in patients with chronic hepatitis CJulie R Jonsson, Alexander R Moschen, Ingrid J Hickman, et al.
BMC Health Services Research|March 23, 2025
Implementation of a nurse-delivered, community-based liver screening and assessment program for people with metabolic dysfunction-associated steatotic liver disease (LOCATE-NAFLD trial)Michelle J Allen, Ruth Tulleners, David Brain, et al.
Plos One|March 18, 2015
Ascites bacterial burden and immune cell profile are associated with poor clinical outcomes in the absence of overt infectionKevin J Fagan, Geraint B Rogers, Michelle Melino, et al.
Plos One|January 6, 2022
Depressive symptoms in non-alcoholic fatty liver disease are identified by perturbed lipid and lipoprotein metabolismDaniel E Radford-Smith, Preya J Patel, Katharine M Irvine, et al.
Patient Preference and Adherence|December 2, 2021
Disparities in Unmet Needs in Indigenous and Non-Indigenous Australians with Cirrhosis: An Exploratory StudyChristina M Bernardes, Paul J Clark, Cath Brown, et al.
Pageof 12

Showing results (41-50 of 113) with videos related to

Sort By:
Pageof 12
The Medical Journal of Australia|September 11, 2025
Cause-specific mortality among Queensland people with cirrhosis, by cirrhosis aetiology and decompensation status, 2007-22: a retrospective cohort studyVikas Bhasker, Jessica R Fong, Paul J Clark, et al.
Hepatology (Baltimore, Md.)|May 4, 2004
Steatosis and liver cell apoptosis in chronic hepatitis C: a mechanism for increased liver injuryMeagan J Walsh, Daina M Vanags, Andrew D Clouston, et al.
International Journal for Equity in Health|February 19, 2020
Hospitalisation for cirrhosis in Australia: disparities in presentation and outcomes for Indigenous AustraliansPatricia C Valery, Paul J Clark, Gregory Pratt, et al.
European Journal of Immunology|May 27, 2004
Virus-specific CD8+ T lymphocytes within the normal human liverScott M Ward, Julie R Jonsson, Sophie Sierro, et al.
Australian Health Review : a Publication of the Australian Hospital Association|March 2, 2013
Use of standardised assessment forms in referrals to hepatology outpatient services: implications for accurate triaging of patients with chronic hepatitis CLeigh Horsfall, Graeme Macdonald, Ian Scott, et al.
Journal of Hepatology|September 6, 2005
Adiponectin and its receptors in patients with chronic hepatitis CJulie R Jonsson, Alexander R Moschen, Ingrid J Hickman, et al.
BMC Health Services Research|March 23, 2025
Implementation of a nurse-delivered, community-based liver screening and assessment program for people with metabolic dysfunction-associated steatotic liver disease (LOCATE-NAFLD trial)Michelle J Allen, Ruth Tulleners, David Brain, et al.
Plos One|March 18, 2015
Ascites bacterial burden and immune cell profile are associated with poor clinical outcomes in the absence of overt infectionKevin J Fagan, Geraint B Rogers, Michelle Melino, et al.
Plos One|January 6, 2022
Depressive symptoms in non-alcoholic fatty liver disease are identified by perturbed lipid and lipoprotein metabolismDaniel E Radford-Smith, Preya J Patel, Katharine M Irvine, et al.
Patient Preference and Adherence|December 2, 2021
Disparities in Unmet Needs in Indigenous and Non-Indigenous Australians with Cirrhosis: An Exploratory StudyChristina M Bernardes, Paul J Clark, Cath Brown, et al.
Pageof 12